TScan Therapeutics
TCRX
#7917
Rank
$0.21 B
Marketcap
$3.94
Share price
-4.37%
Change (1 day)
-5.74%
Change (1 year)

P/S ratio for TScan Therapeutics (TCRX)

P/S ratio as of November 2024 (TTM): 17.2

According to TScan Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.8239. At the end of 2024 the company had a P/S ratio of 25.3.

P/S ratio history for TScan Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202425.391.36%
202313.2380.36%
20222.76-74.01%
202110.6